The United States continues to focus on its counternarcotics efforts in Latin America, adjusting its stance toward Venezuela and Colombia based on recent developments. The U.S. government has decided to remove Venezuela from its list of countries that have failed to meet international commitments against drug trafficking, acknowledging progress under interim President Delcy Rodríguez. This shift indicates an improvement in Venezuela’s cooperation with U.S. counternarcotics objectives.
Venezuela, previously considered non-compliant by Washington, has shown advancements recognized by the Trump administration. According to President Donald Trump, these efforts have been significant enough to warrant Venezuela’s removal from the list, which identifies nations failing to uphold international obligations in drug control. This decision reflects the broader U.S. focus on fostering collaborative efforts across Latin America to combat drug trafficking.
Meanwhile, Colombia remains on the U.S. list of countries deemed to have “failed demonstrably” in meeting international counternarcotics responsibilities over the past year. The White House has highlighted Colombia’s need to make further strides in reducing coca cultivation and cocaine production, as well as in dismantling drug-trafficking networks. President Trump suggested that Colombia’s designation could be reconsidered next year if substantial progress is made in these areas.
Colombian officials have expressed their commitment to addressing the entire drug-trafficking chain within their borders. This includes efforts to tackle illicit crop cultivation, production facilities, trafficking routes, and the financial and international networks that support these operations. Such initiatives align with Colombia’s attempts to meet the expectations set by international partners like the United States.
The latest U.S. decision underscores a continued emphasis on partnership with Latin American countries in the fight against narcotics. Both Venezuela and Colombia are still recognized by the U.S. as major drug-transit or illicit drug-producing nations for the fiscal year 2027. However, Venezuela’s recent progress offers a potential template for Colombia and others striving to enhance their compliance with international drug control standards.